Last reviewed · How we verify
NCT05915910
Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)
trial testing Specimen Donation in Glycogen Storage Disease Type IB in 6 participants. Terminated before completion.
13 March 2024
Quick facts
| Lead sponsor | Sanguine Biosciences |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 6 |
| Start date | 27 April 2023 |
| Primary completion | 13 March 2024 |
| Estimated completion | 13 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Specimen Donation
Conditions studied
- Glycogen Storage Disease Type IB — all drugs for Glycogen Storage Disease Type IB →
Sponsor
Sanguine Biosciences
Who can join
Adults 4 to 85, any sex, with Glycogen Storage Disease Type IB. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to collect whole blood from patients diagnosed with Glycogen storage disease type 1B, which will be used to support the investigation of potential therapies that address the genetic basis of this disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05915910
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Specimen Donation
Trials testing the same drug.
- NCT05910853 — Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia · terminated
- NCT05915897 — Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD) · terminated
Other Sanguine Biosciences trials
Trials by the same sponsor.
- NCT05910853 — Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia · terminated
- NCT05915897 — Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD) · terminated
- NCT05821582 — Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens · withdrawn
- NCT05773196 — Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study · recruiting
- NCT05631119 — Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Ki · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05915910 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanguine Biosciences
- Last refreshed: 19 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05915910.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing